US Patent 8420592 | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Melinta Therapeutics

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

dmfs-not-supported-m-2025-05-19

Chirogate is a professional Prostaglandin manufacturer.

Contact Supplier

Temad- We think of world-class quality.

Contact Supplier

jdmfs-not-supported-m-2025-04-28

Melinta Therapeutics

VISIT THE VIRTUAL BOOTH, Contact Details

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Corporate Presentation

Corporate Presentation

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow, 62 News #PharmaBuzz

Interview #SpeakPharma
Vlog #PharmaReel
Data Compilation #PharmaFlow
62 News #PharmaBuzz

DEVELOPMENTS

7 Drugs in Development

7 Drugs in Development

FINISHED DOSAGE FORMULATIONS

4 FDF Dossiers, 4 FDA Orange Book

4 FDF Dossiers
4 FDA Orange Book

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

2 All

01 2MELINTA THERAP

filter Patent Number Reset all filters

2 All

01 28420592

API Patent Reset all filters

2 All

01 2Blank

FDF Patent Reset all filters

2 All

01 2Blank

filter Expiration Date Reset all filters

2 All

01 22029-08-29

01

MELINTA THERAP

ORITAVANCIN DIPHOSPHATE

India Med Expo

Not Confirmed

MELINTA THERAP

India Med Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-08-29

ORITAVANCIN DIPHOSPHATE

US Patent Number : 8420592

Drug Substance Claim :

Drug Product Claim :

Application Number : 206334

Patent Use Code : U-1570

Delist Requested :

Patent Use Description : TREATMENT OF BACTERIAL...

Patent Expiration Date : 2029-08-29

Portfolio PDF

Product Web Link

Digital Content

02

MELINTA THERAP

ORITAVANCIN DIPHOSPHATE

India Med Expo

Not Confirmed

MELINTA THERAP

India Med Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-08-29

ORITAVANCIN DIPHOSPHATE

US Patent Number : 8420592

Drug Substance Claim :

Drug Product Claim :

Application Number : 214155

Patent Use Code : U-3101

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-08-29

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!